Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
ACC 2024: Recommendations From Dr. Peter Libby
- Written by
-
Peter
Libby
MD
Dr. Peter Libby, member of the PracticeUpdate Cardiology Advisory Board, recommends the following presentation at this year’s American College of Cardiology (ACC 24) meeting held in Atlanta and virtually from April 6–8, 2024.
Saturday, April 6, 2024; 9:30 AM–10:30 AM EDT
Session 402 Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials
402-10 Empagliflozin After Acute Myocardial Infarction: Results of the EMPACT-MI Trial. J Butler, SD Anker, D Bhatt, et al
402-12 CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results. CM Gibson, D Duffy, S Korjian, et al
Sunday, April 7, 2024; 8:00 AM–9:15 AM EDT
Session 405 Late-Breaking Clinical Trials II
405-16 Plozasiran (ARO-APOC3), An Investigational RNAi Therapeutic, Demonstrates Profound And Durable Reductions In APOC-3 And Triglycerides (TG) In Patients With Severe Hypertriglyceridemia (SHTG), SHASTA-2 Final Results. D Gaudet, D Pall, G Watts, et al
Sunday, April 7, 2024; 9:45 AM–11:00 AM EDT
Session 406 Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials III
406-10 Effect Of Edetate Disodium Based Chelation Infusions On Cardiovascular Events In Post-MI Patients With Diabetes: The TACT2 Trial. GA Lamas, KJ Anstrom, A Navas-Acien, et al
Additional Info
Disclosure statements are available on the authors' profiles: